Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma

Pediatric Blood and Cancer

Volumn 58, Issue 2, 2012, Pages 181-184

  Dubois, Steven G ^a   Stempak, Diana ^b   Wu, Bing ^b   Mokhtari, Reza Bayat ^b   Nayar, Rakesh ^c   Janeway, Katherine A ^d,e   Goldsby, Robert ^a   Grier, Holcombe E ^d,e   Baruchel, Sylvain ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Circulating endothelial cells; Osteosarcoma

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; CISPLATIN; DOXORUBICIN; ENDOGLIN; METHOTREXATE; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; ZOLEDRONIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CHILD; CIRCULATING ENDOTHELIAL CELL; CIRCULATING ENDOTHELIAL PRECURSOR CELL; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; OSTEOSARCOMA; PROGNOSIS; PROSPECTIVE STUDIES; STEM CELLS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 83455253930     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23046     Document Type: Article

References (24)

1. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1, 702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776-790.
2. Graves DT, Owen AJ, Antoniades HN. Demonstration of receptors for a PDGF-like mitogen on human osteosarcoma cells. Biochem Biophys Res Commun 1985; 129: 56-62.
3. Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000; 6: 572-577.
4. Lee YH, Tokunaga T, Oshika Y, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999; 35: 1089-1093.
5. Lin F, Zheng SE, Shen Z, et al. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol 2010; [Epub ahead of print].
6. Kaya M, Wada T, Kawaguchi S, et al. Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer 2002; 86: 864-869.
7. Bertolini F, Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nat Rev Cancer 2006; 6: 835-845.
8. Strijbos MH, Gratama JW, Kraan J, et al. Circulating endothelial cells in oncology: Pitfalls and promises. Br J Cancer 2008; 98: 1731-1735.
9. Ahn GO, Brown JM. Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Angiogenesis 2009; 12: 159-164.
10. Garmy-Susini B, Varner JA. Circulating endothelial progenitor cells. Br J Cancer 2005; 93: 855-858.
11. Mancuso P, Bertolini F. Circulating endothelial cells as biomarkers in clinical oncology. Microvasc Res 2010; 79: 224-228.
12. Beerepoot LV, Mehra N, Vermaat JS, et al. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-145.
13. Mancuso P, Burlini A, Pruneri G, et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 3658-3661.
14. Rowand JL, Martin G, Doyle GV, et al. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 2007; 71: 105-113.
15. Duda DG, Cohen KS, Scadden DT, et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-810.
16. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
17. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-1531.
18. Mancuso P, Antoniotti P, Quarna J, et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: Flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15: 267-273.
19. Taylor M, Rossler J, Geoerger B, et al. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies. Clin Cancer Res 2009; 15: 4561-4571.
20. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
21. Rak J, Mitsuhashi Y, Sheehan C, et al. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res 2000; 60: 490-498.
22. Tomlinson J, Barsky SH, Nelson S, et al. Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res 1999; 5: 3516-3522.
23. Norden-Zfoni A, Desai J, Manola J, et al. Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin Cancer Res 2007; 13: 2643-2650.
24. Taddeo A, Presicce P, Brambilla L, et al. Circulating endothelial progenitor cells are increased in patients with classic Kaposi's sarcoma. J Invest Dermatol 2008; 128: 2125-2128.